Anticancer drug discovery and development: natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991
Gespeichert in:
Format: | Tagungsbericht Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Boston u.a.
Kluwer
1994
|
Schriftenreihe: | Developments in oncology
74 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | IX, 403 S. graph. Darst. |
ISBN: | 0792329287 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV009829089 | ||
003 | DE-604 | ||
005 | 19941017 | ||
007 | t| | ||
008 | 940930s1994 xx d||| |||| 10||| eng d | ||
020 | |a 0792329287 |9 0-7923-2928-7 | ||
035 | |a (OCoLC)30516564 | ||
035 | |a (DE-599)BVBBV009829089 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-12 | ||
050 | 0 | |a RC271.C5 | |
082 | 0 | |a 616.99/4061 |2 20 | |
084 | |a XI 7005 |0 (DE-625)153024:12911 |2 rvk | ||
245 | 1 | 0 | |a Anticancer drug discovery and development |b natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 |c ed. by Frederick A. Valeriote ... |
264 | 1 | |a Boston u.a. |b Kluwer |c 1994 | |
300 | |a IX, 403 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Developments in oncology |v 74 | |
650 | 4 | |a Antineoplastic Agents |v Congresses | |
650 | 4 | |a Antineoplastic agents |v Congresses | |
650 | 4 | |a Biological Products |v Congresses | |
650 | 4 | |a Natural products |v Congresses | |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Naturheilmittel |0 (DE-588)4288415-9 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Traverse City Mich. |2 gnd-content | |
689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 0 | 1 | |a Naturheilmittel |0 (DE-588)4288415-9 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 2 | 1 | |a Naturheilmittel |0 (DE-588)4288415-9 |D s |
689 | 2 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Valeriote, Frederick A. |e Sonstige |4 oth | |
711 | 2 | |a Drug Discovery and Development Symposium |n 2 |d 1991 |c Traverse City, Mich. |j Sonstige |0 (DE-588)1600003-1 |4 oth | |
830 | 0 | |a Developments in oncology |v 74 |w (DE-604)BV036830146 |9 74 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006507045&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006507045 |
Datensatz im Suchindex
_version_ | 1823607491088351232 |
---|---|
adam_text |
ANTICANCER DRUG DISCOVERY AND DEVELOPMENT: NATURAL PRODUCTS AND NEW
MOLECULAR MODELS PROCEEDINGS OF THE SECOND DRUG DISCOVERY AND
DEVELOPMENT SYMPOSIUM TRAVERSE CITY, MICHIGAN, USA - JUNE 27-29, 1991
EDITED BY FREDERICK A. VALERIOTE THOMAS H. CORBETT LAURENCE H. BAKER
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE DETROIT, MICHIGAN KLUWER
ACADEMIC PUBLISHERS BOSTON/DORDRECHT/LONDON CONTENTS 1. DISCOVERY OF
NATURAL PRODUCTS FROM MICROALGAE AND MARINE ORGANISMS 1 FRED VALERIOTE,
RICHARD E. MOORE, GREGORY M.L. PATTERSON, VALERIE J. PAUL, PAUL J.
SCHEUER, AND THOMAS CORBETT 2. DISCOVERY OF NATURALLY OCCURRING
ANTITUMOR AGENTS 27 CHING-JER CHANG, CURTIS L. ASHENDEL, ROBERT L.
GEAHLEN, AND JERRY L. MCLAUGHLIN 3. MARINE INVERTEBRATES AND MICROBES AS
SOURCES OF POTENTIAL ANTITUMOR COMPOUNDS 39 ANDREW L. STALEY AND JON
CLARDY 4. NOVEL STRATEGIES FOR THE DISCOVERY OF PLANT-DERIVED ANTICANCER
AGENTS 63 GEOFFREY A. CORDELL, NORMAN R. FARNSWORTH, CHRISTOPHER W.W.
BEECHER, D. DOEL SOEJARTO, A. DOUGLAS KINGHORN, JOHN M. PEZZUTO, MONROE
E. WALL, MANSUKHLAL C. WANI, RONALD R. COBB, MELANIE J. O'NEILL, R.
MURRAY TAIT, AND TIMOTHY J.R. HARRIS 5. A STRATEGY FOR IDENTIFYING NOVEL
INHIBITORS OF DNA TOPOISOMERASEI 85 SIDNEY M. HECHT, DAVID E. BERRY,
LAURIE J. MACKENZIE, ELVA A. SHULTIS, AND JAMES A. CHAN 6. ALTROMYCINS:
A NEW FAMILY OF ANTITUMOR ANTIBIOTICS- DISCOVERY AND BIOLOGICAL
EVALUATION 95 J.B. MCALPINE, J.P. KARWOWSKI, M. JACKSON, G.M. BRILL, S.
KADAM, L. SHEN, J.J. CLEMENT, J. ALDER, AND N.S. BURRES 7. SUPPRESSION
OF HUMAN MELANOMA METASTASIS IN SCID MICE WITH ANTIBODIES TO THE
EGF-RECEPTOR 119 B.M. MUELLER AND R.A. REISFELD 8. GROWTH FACTOR AND
ONCOGENE SIGNALLING AS A TARGET FOR ANTICANCER DRUG DEVELOPMENT 127
GARTH POWIS VI 9. NUCLEOSIDE AND NUCLEOTIDE MODULATION OF ONCOGENIC
EXPRESSION: A NEW APPROACH TO CANCER CHEMOTHERAPY 149 ROLAND K. ROBINS,
RICK A. FINCH, AND THOMAS L. AVERY 10. INTERFERONS IN CANCER THERAPY:
FROM CLINICAL TRIALS TO NEW POTENTIALS IN ANTICANCER DRUG DISCOVERY AND
183 DEVELOPMENT GERHARD G. STEINMANN, GUNTHER R. ADOLF, AND GERHARD
LEITZ 11. SELECTION AND MANIPULATION OF IMMUNOGLOBULINS FOR RADIONUCLIDE
DELIVERY 209 Z. STEPLEWSKI, P. CURTIS, J. HAINFELD, R. MEASE, AND S.
SRIVASTAVA 12. MICROORGANISMS: STRATEGIC SOURCES OF NOVEL ANTI-TUMOR
AGENTS 235 JOSEFINO B. TUNAC 13. THE THERAPEUTIC POTENTIAL OF NOVEL PURE
ANTIESTROGENS 269 A.E. WAKELING 14. PRECLINICAL PHARMACOLOGY AND PHASE I
CLINICAL TRIALS OF TAXOTERE (RP 56976, NSC 628503) 283 MARIE-CHRISTINE
BISSERY, HOWARD BURRIS, AND RICHARD PAZDUR 15. BROPIRIMINE, A
SMALL-MOLECULE BIOLOGICAL RESPONSE MODIFIER AND AN EFFECTIVE ANTITUMOR
AGENT 299 LI H. LI 16. DETERMINANTS OF ETOPOSIDE CYTOTOXICITY IN VITRO
347 RICHARD B. LOCK 17. SCREENING FOR ANTICANCER LEADS FROM MARINE
ORGANISMS IN A MECHANISM-BASED DRUG DISCOVERY PROGRAM 365 P. CREWS, D.L.
SLATE, W.H. GERWICK, F.J. SCHMITZ, R. SCHATZMAN, B. STRULOVICI, P.
CANNON, AND L.M. HUNTER |
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV009829089 |
callnumber-first | R - Medicine |
callnumber-label | RC271 |
callnumber-raw | RC271.C5 |
callnumber-search | RC271.C5 |
callnumber-sort | RC 3271 C5 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | XI 7005 |
ctrlnum | (OCoLC)30516564 (DE-599)BVBBV009829089 |
dewey-full | 616.99/4061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/4061 |
dewey-search | 616.99/4061 |
dewey-sort | 3616.99 44061 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Conference Proceeding Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV009829089</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19941017</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">940930s1994 xx d||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792329287</subfield><subfield code="9">0-7923-2928-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)30516564</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009829089</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7005</subfield><subfield code="0">(DE-625)153024:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticancer drug discovery and development</subfield><subfield code="b">natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991</subfield><subfield code="c">ed. by Frederick A. Valeriote ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston u.a.</subfield><subfield code="b">Kluwer</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 403 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in oncology</subfield><subfield code="v">74</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Products</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Natural products</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Naturheilmittel</subfield><subfield code="0">(DE-588)4288415-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Traverse City Mich.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Naturheilmittel</subfield><subfield code="0">(DE-588)4288415-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Naturheilmittel</subfield><subfield code="0">(DE-588)4288415-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valeriote, Frederick A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Drug Discovery and Development Symposium</subfield><subfield code="n">2</subfield><subfield code="d">1991</subfield><subfield code="c">Traverse City, Mich.</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)1600003-1</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in oncology</subfield><subfield code="v">74</subfield><subfield code="w">(DE-604)BV036830146</subfield><subfield code="9">74</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006507045&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006507045</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1991 Traverse City Mich. gnd-content |
genre_facet | Konferenzschrift 1991 Traverse City Mich. |
id | DE-604.BV009829089 |
illustrated | Illustrated |
indexdate | 2025-02-09T19:00:26Z |
institution | BVB |
institution_GND | (DE-588)1600003-1 |
isbn | 0792329287 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006507045 |
oclc_num | 30516564 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-12 |
owner_facet | DE-355 DE-BY-UBR DE-12 |
physical | IX, 403 S. graph. Darst. |
publishDate | 1994 |
publishDateSearch | 1994 |
publishDateSort | 1994 |
publisher | Kluwer |
record_format | marc |
series | Developments in oncology |
series2 | Developments in oncology |
spelling | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 ed. by Frederick A. Valeriote ... Boston u.a. Kluwer 1994 IX, 403 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Developments in oncology 74 Antineoplastic Agents Congresses Antineoplastic agents Congresses Biological Products Congresses Natural products Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Naturheilmittel (DE-588)4288415-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Traverse City Mich. gnd-content Cytostatikum (DE-588)4068347-3 s Naturheilmittel (DE-588)4288415-9 s DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s Krebs Medizin (DE-588)4073781-0 s Valeriote, Frederick A. Sonstige oth Drug Discovery and Development Symposium 2 1991 Traverse City, Mich. Sonstige (DE-588)1600003-1 oth Developments in oncology 74 (DE-604)BV036830146 74 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006507045&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 Developments in oncology Antineoplastic Agents Congresses Antineoplastic agents Congresses Biological Products Congresses Natural products Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd Naturheilmittel (DE-588)4288415-9 gnd |
subject_GND | (DE-588)4143176-5 (DE-588)4068347-3 (DE-588)4073781-0 (DE-588)4288415-9 (DE-588)1071861417 |
title | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 |
title_auth | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 |
title_exact_search | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 |
title_full | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 ed. by Frederick A. Valeriote ... |
title_fullStr | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 ed. by Frederick A. Valeriote ... |
title_full_unstemmed | Anticancer drug discovery and development natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 ed. by Frederick A. Valeriote ... |
title_short | Anticancer drug discovery and development |
title_sort | anticancer drug discovery and development natural products and new molecular models proceedings of the second drug discovery and development symposium traverse city michigan usa june 27 29 1991 |
title_sub | natural products and new molecular models ; proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27 - 29, 1991 |
topic | Antineoplastic Agents Congresses Antineoplastic agents Congresses Biological Products Congresses Natural products Congresses Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Krebs Medizin (DE-588)4073781-0 gnd Naturheilmittel (DE-588)4288415-9 gnd |
topic_facet | Antineoplastic Agents Congresses Antineoplastic agents Congresses Biological Products Congresses Natural products Congresses Arzneimittelentwicklung Cytostatikum Krebs Medizin Naturheilmittel Konferenzschrift 1991 Traverse City Mich. |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006507045&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV036830146 |
work_keys_str_mv | AT valeriotefredericka anticancerdrugdiscoveryanddevelopmentnaturalproductsandnewmolecularmodelsproceedingsoftheseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganusajune27291991 AT drugdiscoveryanddevelopmentsymposiumtraversecitymich anticancerdrugdiscoveryanddevelopmentnaturalproductsandnewmolecularmodelsproceedingsoftheseconddrugdiscoveryanddevelopmentsymposiumtraversecitymichiganusajune27291991 |